We at Cellogen Therapeutics use advanced cellular engineering methods and gene therapy-based approaches to find curative treatment for various hematological malignancies, solid tumors and hemoglobinopathies.

We have conceptualised and designed state-of-the-arts third and fourth generation CAR constructs (CAR T-cell therapies)  for Blood cancers such as leukaemia, lymphoma. We  have also developed genetic therapies  for Beta-Thalassemia and sickle cell disease, the two most common debilitating blood disorders.

Over the last decade, the impressive clinical outcome of cell and gene-based therapies has given a new hope for patients suffering from life-threatening diseases. Cellular and gene therapies have transformed the therapeutic landscape by providing long-lasting and permanent cure. However, these therapeutic modalities are currently expensive and limited to a few countries. Our vision is to make these revolutionary therapies available to masses, particularly for the patients in India where the majority of the patients cannot afford the cost. We will provide a convenient and cost-effective solution by indigenously manufacturing these therapeutic modalities.

Cellogen Therapeutics

Tanveer Ahmad

This department focuses on conducting experiments and analyses to advance knowledge in various scientific fields.

Scientific Research

This department conducts studies and analyzes data to advance knowledge and innovation in various fields.

Research Department

This department focuses on the development, implementation, and management of artificial intelligence technologies and solutions.

Artificial Intelligence

This department focuses on applying computational methods and tools to analyze biological data and advance research in the field of biology.

Cellogen Therapeutics

Org chart

Teams

Scientific Research

Research Department

Artificial Intelligence

Computational Biology

Offices